认知特征对磁惊厥治疗与电惊厥治疗反应的影响
该开放标签非随机对照试验纳入263例精神分裂症和135例重性抑郁障碍患者,通过潜在剖面分析识别认知特征。结果显示MST与ECT症状改善相似,但MST认知保护更优;基线认知特征影响ECT疗效,而MST疗效在不同认知特征间相对一致。
要点
- MST与ECT均显著降低精神分裂症和抑郁障碍症状评分。
- MST在信息处理速度等认知保护方面优于ECT。
- 基线认知特征影响ECT疗效,MST疗效跨认知特征较一致。
核心结论
- MST与ECT临床疗效相似,但MST认知保护优势更明显。
- 基线认知特征影响ECT结局,而MST效果在不同认知特征间相对一致。
研究设计与样本
- 开放标签非随机对照试验,2020年10月至2024年6月招募263例精神分裂症和135例重性抑郁障碍患者。
- 通过潜在剖面分析识别认知特征,其中54例精神分裂症和119例重性抑郁障碍患者接受MST或ECT,每周完成3或4次治疗。
- MST经顶点给予,设备输出100%、频率100 Hz。
主要发现
- MST和ECT均使症状评分显著下降。
- MST提供更好的认知获益,尤其信息处理速度方面。
- 精神分裂症中最佳认知组接受ECT症状减轻最强,抑郁障碍中差认知组接受ECT症状减轻最强。
- MST对精神分裂症和抑郁障碍的两个认知组疗效相当。
关键数值与推荐
- 疗效采用阳性与阴性症状量表(PANSS)和24项汉密尔顿抑郁量表(HAM-D)评估。
- 认知功能采用MATRICS共识认知成套测验(MCCB)评估。
- 结局轨迹采用线性混合效应模型分析。
临床怎么用
- 对需保护认知功能的患者,MST可作为与ECT疗效相当的选择。
- 选择ECT时应考虑基线认知特征以预测症状改善程度。
- MST在不同认知特征患者中疗效较一致,适用范围可能更广。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Magnetic seizure therapy (MST) and electroconvulsive therapy (ECT) are effective treatments for schizophrenia (SCZ) and major depressive disorder (MDD), with MST offering advantages in preserving cognitive function. Although cognitive profiles are known to influence treatment outcomes, their role in moderating response to seizure therapies remains unclear. We conducted an open-label, non-randomized controlled trial to compare the efficacy of MST and ECT across different cognitive profiles. From October 2020 to June 2024, we recruited 263 patients with SCZ and 135 patients with MDD, identifying cognitive profiles through latent profile analysis. Among them, 54 patients with SCZ and 119 patients with MDD received MST or ECT, completing 3 or 4 sessions per week. MST was administered at 100% device output and 100 Hz over the vertex. Treatment effectiveness was measured using the Positive and Negative Syndrome Scale and the 24-item Hamilton Depression Rating Scale, while cognitive function with the MATRICS Consensus Cognitive Battery. We analyzed outcomes trajectories using a linear mixed-effects model. Results indicated significant symptom score reductions for both MST and ECT. MST provided better cognitive benefits, especially in information processing speed. Among cognitive profiles, the Optimal-Cognition Group in SCZ receiving ECT showed the strongest symptom reduction, while the Poor-Cognition Group in MDD receiving ECT exhibited the greatest symptom reduction. In contrast, MST had comparable treatment effects on both cognitive groups in SCZ and MDD. In conclusion, MST and ECT yielded similar clinical outcomes, but MST provided better cognitive protective advantages; baseline cognitive profiles appeared to influence ECT outcomes, whereas MST effects were relatively consistent across cognitive profiles.
引用
- Guo Z, Zhao W, Li J, et al. Exploring the impact of cognitive profiles on the response to magnetic seizure therapy and electroconvulsive therapy. Mol Psychiatry. 2026. PMID: 41703265. doi:10.1038/s41380-026-03494-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。